Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference37 articles.
1. World Health Organization. Globocan 2020; Cancer incidence and mortality statistics worldwide and by region. https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf.
2. Chan BA, Coward JIG. Chemotherapy advances in small-cell lung cancer. J Thorac Dis. 2013;5(S5):565–78.
3. Farago AF, Drapkin BJ, Lopez-Vilarino de Ramos JA, et al. ATLANTIS: a phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line. Future Oncol. 2019;15(3):231–9. https://doi.org/10.2217/fon-2018-0597.
4. Paz-Ares L, Spigel D, Chen Y, et al. Initial efficacy and safety results of irinotecan liposome injection (NAL-IRI) in patients with small cell lung cancer. J Clin Oncol. 2019;37(15_Supp l):8562. https://doi.org/10.1200/JCO.2019.37.15_suppl.8562.
5. Yu G, Cai Q, Xu X, et al. Anlotinib-containing regimen for advanced small-cell lung cancer: a protocol of meta-analysis. PLoS ONE. 2021;16(3): e0247494. https://doi.org/10.1371/journal.pone.0247494.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献